CompletedNot Applicable

HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults

Portugal199 participantsStarted 2021-09-01

Plain-language summary

The main goal of this research is to assess the efficacy of a 10-week home-delivered cognitive-emotional intervention program for homebound older adults presenting Mild Cognitive Impairment (MCI) and depressive and/or anxiety symptoms. The Homebound Elderly People Psychotherapeutic Intervention (HEPPI) combines cognitive training, psychotherapeutic techniques, and compensatory strategy training, and was designed to optimize memory function and to reduce depressive or anxious symptomatology of these older adults. A two-arm randomized controlled trial (RCT) is conducted to investigate the efficacy of the HEPPI among the homebound older population.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Homebound older adults aged 65 years and older; * MoCA score 1 to 1.5 standard deviation below the mean for age- and education- adjusted norms; * FCSRT total immediate and delayed recall scores ≤ 35 and ≤ 12, respectively; * Presence of subjective memory complaints (SMCS score ≥ 3); * Presence of depressive symptomatology (GDS-30 score ≥ 11); * Presence of anxious symptomatology (GAI score ≥ 8); * No significant impact from cognitive impairment on daily functional capacity; * Residence in mainland Portugal; Exclusion Criteria: * Presence or history of significant neurological conditions; * Presence of severe psychiatric illnesses; * Presence of comorbid medical conditions associated with cognition decline; * Use of psychotropic medication for less than three months; * Presence of alcoholism or toxicomania; * Significant impairment of vision, hearing, communication, or manual dexterity.

What they're measuring

Changes in Episodic Memory

Timeframe: Baseline, post-intervention, and 3-month follow-up

Changes in Depressive Symptomatology

Timeframe: Baseline, post-intervention, and 3-month follow-up

Changes in Anxious Symptomatology

Timeframe: Baseline, post-intervention, and 3-month follow-up

Trial details

NCT IDNCT05499767

SponsorUniversity of Coimbra

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-30

View on ClinicalTrials.gov More Mild Cognitive Impairment trials

Plain-language summary

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.